Noticias de TARS_US

Noticias del mercado

Últimas noticias sobre TARS_US — 66 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: TARS_US ✕ 66 resultados
18/03/2026 TARS_US — GuruFocus ES ← EN
Alerta de venta interna: LINK WILLIAM J PHD vende 12.500 acciones de Ta
16/03/2026 TARS_US — Stock Titan
Tarsus Pharmaceuticals (TARS) files Section 144 notice to sell 12,500 shares
09/03/2026 TARS_US — Orange County Business Journal
Tarsus Reports Soaring Xdemvy Sales in Q4, Full Year
09/03/2026 TARS_US — TipRanks ES ← EN
Tarsus Pharmaceuticals apuesta fuerte por el crecimiento de XDEMVY
06/03/2026 TARS_US — Yahoo Finance
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating
26/02/2026 TARS_US — GlobeNewswire ES ← EN
Tarsus participará en las próximas conferencias de inversores
26/02/2026 TARS_US — Stock Titan
Stream Tarsus Pharma at TD Cowen and Barclays investor events in March
25/02/2026 TARS_US — VisionMonday.com
Tarsus Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
24/02/2026 TARS_US — Yahoo Finance
Tarsus Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary
24/02/2026 TARS_US — Seeking Alpha
Tarsus Pharmaceuticals: Q4 Results Highlight Xdemvy Blockbuster Potential (NASDAQ:TARS)
24/02/2026 TARS_US — GuruFocus
Tarsus Pharmaceuticals (TARS) Shares Surge Over 11%
23/02/2026 TARS_US — TradingView
Tarsus Pharmaceuticals, Inc. SEC 10-K Report
23/02/2026 TARS_US — Investing.com
Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth
23/02/2026 TARS_US — Yahoo Finance
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates
23/02/2026 TARS_US — Yahoo Finance
Tarsus Pharmaceuticals Q4 Earnings Call Highlights
23/02/2026 TARS_US — Yahoo Finance
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
23/02/2026 TARS_US — Stock Titan ES ← EN
Las gotas para los ojos generan 451 millones de dólares en ventas mientras Tarsus prueba una píldora para detener la enfermedad de Lyme
20/02/2026 TARS_US — VisionMonday.com
Tarsus Pharmaceuticals Appoints David Pyott to its Board of Directors
18/02/2026 TARS_US — GlobeNewswire
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical
18/02/2026 TARS_US — BioSpace
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors

Página 3 de 4

keyboard_arrow_up